Valuation: CVRx, Inc.

Market Cap 63.42M 54.86M 51.23M 47M 88.39M 6.04B 89.8M 601M 236M 3.03B 238M 233M 10B P/E 2026 *
-1.18x
P/E 2027 * -1.27x
Enterprise Value 73.92M 63.94M 59.71M 54.78M 103M 7.04B 105M 701M 275M 3.53B 278M 272M 11.66B EV / Sales 2026 *
1.26x
EV / Sales 2027 * 1.57x
Free-Float
85.48%
Yield 2026 *
-
Yield 2027 * -
1 day-59.76%
1 week-53.82%
Current month-53.82%
1 month-58.36%
3 months-67.35%
6 months-63.51%
Current year-66.34%
1 week 2.3
Extreme 2.3
6
1 month 2.3
Extreme 2.3
6
Current year 2.3
Extreme 2.3
9.84
1 year 2.3
Extreme 2.3
11.3
3 years 2.3
Extreme 2.3
33.14
5 years 2.3
Extreme 2.3
33.14
10 years 2.3
Extreme 2.3
33.14
Manager TitleAgeSince
Chief Executive Officer 60 12/02/2024
Director of Finance/CFO 43 01/10/2020
Chief Operating Officer 57 11/08/2025
Director TitleAgeSince
Director/Board Member 61 01/10/2008
Director/Board Member 57 01/07/2020
Director/Board Member 52 01/07/2020
Date Insider Type Main position Quantity % Market Cap.
2/27/26 A Free

Chief Executive Officer

404,763 1.5443%
2/27/26 A Free

Chief Operating Officer

38,000 0.1450%
2/27/26 A Free

Executive/Senior Manager

90,964 0.3471%
Change 5-day change 1-year change 3-year change Capi.($)
-59.76%-53.82%-65.56%-86.44% 63.42M
-0.06%+1.08%+34.86%+28.50% 12.79B
-0.29%-0.17%+21.63%+22.61% 6.81B
+0.79%+2.67%+57.15%+28.07% 6.21B
+6.41%+8.59% - - 5.5B
-0.58%-8.31%-25.19%+34.98% 4.36B
+1.30%-2.64%-22.77%-18.05% 4.04B
+4.46%+10.44%+42.40%-39.12% 1.91B
-0.51%-5.18%-15.07%+200.51% 1.75B
+3.67%+6.92%+68.57%+0.78% 1.71B
Average -4.46%-3.80%+10.67%+19.09% 4.51B
Weighted average by Cap. +1.11%+1.32%+23.04%+26.35%

Financials

2026 *2027 *
Net sales 58.81M 50.87M 47.51M 43.58M 81.97M 5.6B 83.27M 557M 219M 2.81B 221M 216M 9.27B 67.87M 58.7M 54.82M 50.29M 94.59M 6.46B 96.09M 643M 252M 3.24B 255M 249M 10.7B
Net income -53.51M -46.29M -43.22M -39.65M -74.58M -5.09B -75.77M -507M -199M -2.55B -201M -197M -8.44B -51.21M -44.3M -41.37M -37.95M -71.38M -4.87B -72.51M -485M -191M -2.44B -192M -188M -8.08B
Net Debt 10.5M 9.09M 8.48M 7.78M 14.64M 1B 14.87M 99.54M 39.07M 501M 39.44M 38.58M 1.66B 42.94M 37.14M 34.68M 31.82M 59.85M 4.09B 60.8M 407M 160M 2.05B 161M 158M 6.77B
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
07/08/26 $2.390 -59.76% 14,773,453
06/08/26 $5.940 +6.45% 591,250
05/08/26 $5.580 +1.64% 174,994
04/08/26 $5.490 -0.18% 134,536
03/08/26 $5.500 +6.28% 128,811
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
2.390USD
Average target price
5.917USD
Spread / Average Target
+147.56%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CVRX Stock